Review
Open access
Jul 2026
Antibody-drug conjugates in the treatment of breast cancer
Overall, the results suggest that despite the challenges, this technology represents a significant advance in breast cancer therapy and that the integration of combined and personalized strategies may enhance antibody efficacy, overcome current barriers and contribute to better clinical outcomes.
A. D. da Cruz, M. Lima, Bárbara Sentanin et al.
· International Journal of Adv... · 0 citations